Skip to main content
. 2021 Mar 5;70(9):312–315. doi: 10.15585/mmwr.mm7009a4

TABLE 2. Estimated number of SARS-CoV-2 infections based on seroprevalence estimates and the number of reported COVID-19 cases at of the end of the preceding month among persons aged <18 years — Mississippi, May 17–September 19, 2020.

Specimen collection date Estimated seroprevalence* % (95% CI) Estimated cumulative infections, no. (95% CI) Cumulative reported cases§ (report date) Estimated infection/reported case ratio (95% CI)
May 17–31
2.5 (0.9–5.3)
17,461 (6,286–37,016)
256 (Apr 30)
68.2 (24.6–144.6)
Jun 1–30
5.2 (3.7–8.0)
36,318 (25,842–55,874)
1,083 (May 31)
33.5 (23.9–51.6)
Jul 1–31
8.6 (6.4–12.4)
60,064 (44,699–86,604)
2,869 (Jun 30)
20.9 (15.6–30.2)
Aug 1–31
13.0 (10.3–17.6)
90,795 (71,937–122,922)
6,439 (Jul 31)
14.1 (11.2–19.1)
Sep 1–19 16.3 (12.9–22.0) 113,842 (90,096–153,652) 8,993 (Aug 31) 12.7 (10.0–17.1)

Abbreviation: CI = confidence interval.

* Standardized to the race/ethnicity distribution of the Mississippi population aged <18 years using weights derived from the 2019 U.S. Census; 95% CIs were calculated for race/ethnicity–weighted SARS-CoV-2 seropositivity in the sample accounting for assay test performance.

Race/ethnicity–standardized seroprevalence estimates for each period applied to the 2019 Mississippi population aged <18 years = 698,420 (https://www.census.gov).

§ Cumulative number of confirmed and probable COVID-19 cases in persons aged <18 years reported to Mississippi State Department of Health as of the end of the preceding month.